In an exciting medical breakthrough, the U.S. Food and Drug Administration (FDA) has approved two sickle cell treatments, including the first to use gene-editing tool CRISPR.
Hundreds of thousands of people around the world — mostly people of colour — live with this painful condition that shortens a person's lifespan.
Farah Nasser explains how the new therapy works, and what else it could be used for.
For more info, please go to https://globalnews.ca/news/10157599/crispr-gene-therapy-sickle-cell-disease/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #US #Health
Hundreds of thousands of people around the world — mostly people of colour — live with this painful condition that shortens a person's lifespan.
Farah Nasser explains how the new therapy works, and what else it could be used for.
For more info, please go to https://globalnews.ca/news/10157599/crispr-gene-therapy-sickle-cell-disease/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #US #Health
- Category
- U.S. & Canada
- Tags
- global news, sickle cell, U.S. FDA
Sign in or sign up to post comments.
Be the first to comment